Liu Y, Ma X, Wu X, Hou X, et al. Zanubrutinib is effective in non-germinal-center B-cell-like diffuse large B-cell lymphoma with mutated CD79B, high TCL1A expression, or over- expressed MYC/BCL-2. Leuk Lymphoma 2024 May 22:1-11. doi: 10.1080/10428194.2024.2343779.
PMID: 38775302